A prospective imaging study assessed structural and diffusion MRI of the cervical spinal cord (CSC) in patients with mucopolysaccharidosis types I and VI. The cohort included 17 patients with MPS I and 3 with MPS VI (mean age 19±7 years) and was compared with 19 age-matched healthy controls (20±7 years). The study team analyzed macrostructural measures—cross-sectional area and diameters—and microstructural diffusion metrics including fractional anisotropy (FA) and radial diffusivity (RD), together with mean and axial diffusivities. Investigators reported statistically significant reductions in CSC cross-sectional area and anterior–posterior diameter at upper cervical levels in patients versus controls.
Short sentence: Conventional MRI detected upper-cord atrophy. Longer sentence: When diffusion metrics were added, the authors observed complementary evidence of microstructural compromise that extended through much of the CSC, capturing abnormalities not always visible on standard morphologic reads.
The authors documented that structural damage was not confined to the visually obvious maximal compression site. Reduced cross-sectional area and diameter localized to upper cervical levels, yet diffusion abnormalities—signs of microstructural injury—were present throughout the cervical cord. The team emphasized that restricted foramen magnum space was linked to microstructural damage at lower cervical levels, even when there was no overt macrostructural compression recorded at those segments. In other words, regional stenosis can produce downstream or remote tissue injury measurable by diffusion MRI.
Diffusion-weighted measures diverged between patients and controls. The cohort showed lower FA and higher RD across the CSC relative to healthy controls, with the differences surviving false-discovery-rate correction (reported pFDR<0.05). The report indicates these microstructural signals were widespread, not limited to the immediately compressed segments. Lower FA in spinal cord white matter typically reflects reduced fiber coherence or integrity; higher RD often signals demyelination or increased perpendicular diffusivity. The authors did not provide histopathologic confirmation in this preprint; they reported only the MRI metrics and their spatial patterns.
The dataset linked imaging biomarkers to clinical status. Lower measures of CSC integrity correlated with more advanced growth retardation (reported p<0.001). Morphological and microstructural metrics were sensitive to both the degree of CSC compression and clinical myelopathy severity (reported pFDR<0.05). The investigators interpreted these imaging metrics as candidate biomarkers for early detection and characterization of myelopathy in MPS I and VI.
Among patients who had undergone hematopoietic stem cell transplantation (HSCT), the team found that earlier transplant timing correlated with preserved upper CSC morphology (reported p<0.05). The preprint does not provide detailed HSCT dosing, conditioning regimens, nor the precise timing windows in this summary; those specifics were not reported in the abstract. The authors therefore present an association between treatment timing and imaging outcomes, without causal inference in this observational cohort.
The investigators observed genotype-associated differences in imaging patterns. Distinct neuroimaging phenotypes were reported across MPS genotypes, with group-level differences meeting FDR-corrected significance thresholds (reported pFDR<0.05). The preprint does not expand in the abstract on the exact phenotype descriptors or segment-by-segment genotype contrasts; readers must consult the full manuscript and supplementary material for granular comparisons.
This report is a preprint and has not been peer reviewed; the authors explicitly state the work should not yet guide clinical practice. Sample sizes are modest, particularly for MPS VI, and the abstract does not list details such as scanner field strength or diffusion acquisition parameters—those were not reported in the abstract. The study team notes that all data are available on reasonable email request to Dr. Nestrasil, and that the in-house code for automated image and statistical analyses is hosted at the provided GitHub repository: https://github.com/umn-milab/mps-sc-resolve. Institutional review board approvals were obtained through the University of Minnesota (protocol IDs listed in the full manuscript). The authors reported no competing interests.
Concrete unanswered questions remain: how these MRI biomarkers track longitudinal progression, whether diffusion abnormalities predict functional decline, and what thresholds would prompt surgical or medical intervention. The preprint documents cross-sectional associations and candidate imaging markers, but prospective validation and larger genotype-stratified cohorts will be required before these metrics can be implemented as clinical decision tools.